Skip to main content

Table 2 Multivariable-adjusted odds ratios of potential risk factors for hemoptysis

From: Association of serum antibodies against the Mycobacterium avium complex and hemoptysis: a cross-sectional study

Risk factors

Number of hemoptysis events/cases (%)

Multivariable-adjusted OR (95% CI)

P value

Exposure group

Reference group

MAC-Ab positive (vs. negative)

46/109 (42.2%)

10/46 (21.7%)

2.79 (1.15–7.44)

0.03

Age (per 1-year increase)

N/A

N/A

0.99 (0.96–1.03)

0.62

Male gender (vs. female)

8/40 (20.0%)

48/115 (41.7%)

0.50 (0.19–1.22)

0.14

BMI (per 1 kg/m2 increase)

N/A

N/A

0.96 (0.85–1.09)

0.52

Nodular bronchiectatic disease (vs. others)

42/114 (36.8%)

14/41 (34.1%)

> 999.99 (0.02- > 999.99)

0.96

Fibrocavitary disease (vs. others)

14/40 (35.0%)

42/115 (36.5%)

> 999.99 (0.01- > 999.99)

0.96

Number of NTM species (per increase of 1)

N/A

N/A

1.87 (0.75–4.61)

0.17

  1. Adjustment was made for MAC-Ab presence, age, gender, BMI, nodular bronchiectatic disease, fibrocavitary disease, and the number of NTM species identified
  2. OR odds ratio, 95% CI 95% confidence interval, MAC-Ab antibody against the Mycobacterium avium complex, N/A not applicable, BMI body mass index, NTM nontuberculous mycobacteria